Jaguar Health (NASDAQ:JAGX) reported quarterly losses of $(0.40) per share. This is a 48.15 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $2.63
Companies Reporting Before The Bell
• Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Dr. Chaturvedi continues to serve as Chair of company's Scientific Advisory Board
Dr. Chaturvedi continues to provide leadership to the development of two crofelemer pipeline indications, with anticipated key
Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 10.90% at $0.70 on continued momentum after the company last week announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Mid
Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 31.2% at $0.70 after the company announced an agreement granting Quadri Pharmaceuticals for exclusive promotional, commercialization and distribution rights for specified human indications of crofelemer in the Middle East.
Gainers
Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft Teams.
Jaguar Health (NASDAQ:JAGX) brought in sales totaling $2.08 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 17.44%, resulting in a loss of $14.32 million.